Increase of targeted anticancer therapies led to the beginning of a new era of cancer treatment, partly instead of classical chemotherapies, partly suppleme
We discovered an immunogenic 90kD glycoprotein tumor-associated antigen (TAA), and developed a murine monoclonal antibody based ELISA to detect TAA specific